Experts Question Why Some Drugmakers Were Left Off ” Operation Warp Speed”
June 9, 2020
By Neozene

This article originally appeared in FiercePharma and was written by Eric Sagonowsky  All eyes are on a handful of drug companies after news that the U.S. is prioritizing five COVID-19 vaccine programs. But since the selections went public, experts have been raising questions about the process and the drugmakers that were left off. Earlier this week, The New York Times reported that AstraZeneca, Pfizer, Merck, Johnson & Johnson and Moderna had scored “finalist” status at Operation Warp Speed, an aggressive program to deliver COVID-19 vaccines to Americans this year. Four of

Read More

COVID-19 ” Operation Warp Speed” Vaccine Finalists Selected
June 3, 2020
By Neozene

This article originally appeared in FiercePharma and was written by Eric Sagonowsky  The Trump administration has selected its COVID-19 vaccine finalists for Operation Warp Speed, which aims to deliver safe and effective coronavirus vaccines to Americans by the end of the year, The New York Times reports. The finalists—from AstraZeneca, Merck, Pfizer, Johnson & Johnson and Moderna—have a clear Big Pharma slant, with biotechs like Inovio and Novavax being left off the list. Moderna is the smallest company among the group, but the biotech is pressing ahead into mid- and late-stage

Read More

Neozene Obtains PPE Gear for Clients, Helping Them Get Back to Work Safely
May 6, 2020
By Neozene

In response to the ongoing battle against COVID-19 (“Coronavirus”), Neozene has been working tirelessly to find a way to provide its partners with personal protective equipment (PPE). We are proud to announce that our efforts have been successful. Neozene, Inc. is pleased to offer our close partners access to Personal Protective Equipment (PPE), procured through the Neozene Board of Physicians. For many years, Neozene has run clinical trials and FDA compliance efforts for pharmaceutical and medical device companies across the nation. With the tagline “Safety in Medicine,” Neozene consistently goes above

Read More